Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Ann E Berman. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Ann E Berman har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:L / Loews Corporation | Director | 6 435 |
US:IMRX / Immuneering Corporation | Director | 67 465 |
US:US138098AA66 / CANTEL MEDICAL CORP CONV 3.25% 05/15/2025 144A | Director | 0 |
US:278265AC7 / Eaton Vance 6.5% Senior Notes 10/2/17 | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Ann E Berman. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IMRX / Immuneering Corporation - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IMRX / Immuneering Corporation. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IMRX / Immuneering Corporation. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Ann E Berman som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-03 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −1 422 | 6 435 | −18,10 | 96,67 | −137 465 | 622 071 |
2025-09-03 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −828 | 7 857 | −9,53 | 96,70 | −80 068 | 759 772 |
2025-09-03 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 8 685 | 34,97 | 35,52 | 79 920 | 308 491 |
2025-07-01 |
|
4 | L |
LOEWS CORP
Common Stock |
A - Award | 149 | 6 435 | 2,37 | ||||
2025-06-03 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −1 273 | 6 286 | −16,84 | 88,82 | −113 068 | 558 323 |
2025-06-03 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −977 | 7 559 | −11,45 | 88,74 | −86 699 | 670 786 |
2025-06-03 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 8 536 | 35,79 | 38,46 | 86 535 | 328 295 |
2025-05-14 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 288 | 6 286 | 25,77 | ||||
2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −1 197 | 4 998 | −19,32 | 86,90 | −104 019 | 434 326 |
2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 053 | 6 195 | −14,53 | 86,89 | −91 495 | 538 284 |
2025-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 7 248 | 45,02 | 40,61 | 91 372 | 294 341 |
2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −1 146 | 4 998 | −18,65 | 86,48 | −99 106 | 432 227 |
2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 104 | 6 144 | −15,23 | 86,80 | −95 827 | 533 299 |
2024-12-03 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 7 248 | 45,02 | 42,52 | 95 670 | 308 185 |
2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −1 087 | 4 998 | −17,86 | 81,38 | −88 460 | 406 737 |
2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 163 | 6 085 | −16,05 | 81,36 | −94 622 | 495 076 |
2024-09-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 7 248 | 45,02 | 41,98 | 94 455 | 304 271 |
2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −963 | 4 998 | −16,16 | 75,80 | −72 995 | 378 848 |
2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 287 | 5 961 | −17,76 | 76,59 | −98 571 | 456 553 |
2024-06-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 7 248 | 45,02 | 43,83 | 98 618 | 317 680 |
2024-05-09 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 706 | 4 998 | 51,82 | ||||
2024-03-19 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 57 965 | 67 465 | 610,16 | 2,13 | 123 436 | 143 667 | |
2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −951 | 3 292 | −22,41 | 75,02 | −71 344 | 246 966 |
2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 299 | 4 243 | −23,44 | 75,07 | −97 516 | 318 522 |
2024-03-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 5 542 | 68,35 | 43,37 | 97 582 | 240 357 |
2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −715 | 3 292 | −17,84 | 70,16 | −50 164 | 230 967 |
2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 535 | 4 007 | −27,70 | 70,08 | −107 573 | 280 811 |
2023-12-04 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 5 542 | 68,35 | 47,84 | 107 640 | 265 129 |
2023-09-05 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −561 | 3 292 | −14,56 | 62,56 | −35 096 | 205 948 |
2023-09-05 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 689 | 3 853 | −30,48 | 62,58 | −105 698 | 241 121 |
2023-09-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 5 542 | 68,35 | 46,99 | 105 728 | 260 419 |
2023-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | X | −474 | 3 292 | −12,59 | 56,30 | −26 686 | 185 340 |
2023-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | X | −1 776 | 3 766 | −32,05 | 56,28 | −99 953 | 211 950 |
2023-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | X | 2 250 | 5 542 | 68,35 | 44,44 | 99 990 | 246 286 |
2023-05-10 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 567 | 3 292 | 90,84 | ||||
2023-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −625 | 1 725 | −26,60 | 60,98 | −38 112 | 105 190 | |
2023-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 625 | 2 350 | −40,88 | 60,75 | −98 719 | 142 762 | |
2023-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2 250 | 3 975 | 130,43 | 43,89 | 98 752 | 174 463 | |
2022-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −698 | 1 725 | −28,81 | 57,90 | −40 414 | 99 878 | |
2022-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 552 | 2 423 | −39,04 | 58,66 | −91 040 | 142 133 | |
2022-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2 250 | 3 975 | 130,43 | 40,47 | 91 058 | 160 868 | |
2022-09-06 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −572 | 1 725 | −24,90 | 54,90 | −31 403 | 94 702 | |
2022-09-06 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 678 | 2 297 | −42,21 | 55,16 | −92 558 | 126 703 | |
2022-09-06 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2 250 | 3 975 | 130,43 | 41,14 | 92 565 | 163 532 | |
2022-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −883 | 1 725 | −33,86 | 64,55 | −56 998 | 111 349 | |
2022-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 367 | 2 608 | −34,39 | 65,48 | −89 511 | 170 772 | |
2022-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2 250 | 3 975 | 130,43 | 39,80 | 89 550 | 158 205 | |
2022-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
M - Exercise | −1 725 | 0 | −100,00 | ||||
2022-05-11 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 725 | 1 725 | |||||
2022-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1 567 | 1 567 | |||||
2022-03-15 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 6 000 | 9 500 | 171,43 | 6,40 | 38 400 | 60 800 | |
2022-03-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −2 250 | 0 | −100,00 | ||||
2022-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −797 | 0 | −100,00 | 59,89 | −47 732 | ||
2022-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 453 | 797 | −64,58 | 61,02 | −88 662 | 48 633 | |
2022-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 2 250 | 2 250 | 39,41 | 88 672 | 88 672 | ||
2021-12-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2021-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −459 | 0 | −100,00 | 54,71 | −25 112 | ||
2021-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 041 | 459 | −69,40 | 54,43 | −56 662 | 24 983 | |
2021-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 37,78 | 56 670 | 56 670 | ||
2021-09-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2021-09-01 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −561 | 0 | −100,00 | 55,62 | −31 203 | ||
2021-09-01 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −939 | 561 | −62,60 | 55,97 | −52 556 | 31 399 | |
2021-09-01 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 35,04 | 52 560 | 52 560 | ||
2021-08-04 |
|
4 | IMRX |
Immuneering Corp
Class A Common Stock |
P - Purchase | 3 500 | 3 500 | 15,00 | 52 500 | 52 500 | ||
2021-07-30 |
|
4 | IMRX |
Immuneering Corp
Stock Option |
A - Award | −28 371 | 28 371 | −50,00 | ||||
2021-06-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2021-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −429 | 0 | −100,00 | 58,68 | −25 174 | ||
2021-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 071 | 429 | −71,40 | 58,84 | −63 018 | 25 242 | |
2021-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 42,02 | 63 030 | 63 030 | ||
2021-06-02 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
D - Sale to Issuer | −4 159 | 0 | −100,00 | 80,59 | −335 174 | ||
2021-05-12 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1 725 | 1 725 | |||||
2021-04-06 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
S - Sale | −5 500 | 4 159 | −56,94 | 82,41 | −453 255 | 342 743 | |
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Phantom Stock |
D - Sale to Issuer | −3 252 | 0 | −100,00 | 73,00 | −237 396 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | −4 045 | 0 | −100,00 | 31,10 | −125 800 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Deferred Stock |
D - Sale to Issuer | −3 363 | 0 | −100,00 | 73,00 | −245 499 | ||
2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Deferred Stock |
D - Sale to Issuer | −2 477 | 0 | −100,00 | 73,00 | −180 821 | ||
2021-03-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2021-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −170 | 0 | −100,00 | 49,36 | −8 391 | ||
2021-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 330 | 170 | −88,67 | 48,62 | −64 665 | 8 265 | |
2021-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 43,14 | 64 710 | 64 710 | ||
2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 3 252 | 0,53 | ||||
2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 18 | 3 363 | 0,54 | ||||
2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 13 | 2 477 | 0,53 | ||||
2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 193 | 3 235 | 6,34 | ||||
2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 200 | 3 345 | 6,36 | ||||
2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 147 | 2 464 | 6,34 | ||||
2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 19 | 3 042 | 0,63 | ||||
2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 20 | 3 145 | 0,64 | ||||
2020-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 2 317 | 2 317 | |||||
2020-11-03 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
M - Exercise | −3 303 | 0 | −100,00 | ||||
2020-11-03 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 20 | 3 303 | 0,61 | ||||
2020-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −3 303 | 0 | −100,00 | 59,79 | −197 486 | ||
2020-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 3 303 | 3 303 | |||||
2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 30 | 3 023 | 1,00 | ||||
2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 31 | 3 125 | 1,00 | ||||
2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 32 | 3 283 | 0,98 | ||||
2020-08-03 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
A - Award | 1 935 | 9 659 | 25,05 | ||||
2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 34 | 2 993 | 1,15 | ||||
2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 35 | 3 094 | 1,14 | ||||
2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 37 | 3 251 | 1,15 | ||||
2020-05-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 292 | 3 292 | |||||
2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 959 | 0,82 | ||||
2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 25 | 3 059 | 0,82 | ||||
2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 26 | 3 214 | 0,82 | ||||
2019-12-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −11 777 | 0 | −100,00 | ||||
2019-12-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −11 777 | 0 | −100,00 | 47,26 | −556 587 | ||
2019-12-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 11 777 | 11 777 | 34,84 | 410 311 | 410 311 | ||
2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 26 | 2 935 | 0,89 | ||||
2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 28 | 3 188 | 0,89 | ||||
2019-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 034 | 3 034 | |||||
2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 909 | 0,83 | ||||
2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 26 | 3 160 | 0,83 | ||||
2019-08-02 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
A - Award | 713 | 7 724 | 10,17 | ||||
2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 25 | 2 885 | 0,87 | ||||
2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 27 | 3 134 | 0,87 | ||||
2019-05-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1 979 | 1 979 | |||||
2019-03-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −1 399 | 0 | −100,00 | 48,24 | −67 488 | ||
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −4 601 | 1 399 | −76,68 | 47,96 | −220 664 | 67 096 | |
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 6 000 | 33,33 | 38,99 | 58 485 | 233 940 | |
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 4 500 | 50,00 | 37,82 | 56 730 | 170 190 | |
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 3 000 | 100,00 | 33,12 | 49 680 | 99 360 | |
2019-03-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 37,26 | 55 890 | 55 890 | ||
2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 27 | 2 860 | 0,95 | ||||
2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 30 | 3 107 | 0,97 | ||||
2018-12-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 1 960 | 0,14 | ||||
2018-12-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 6 | 4 708 | 0,14 | ||||
2018-11-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 22 | 2 833 | 0,78 | ||||
2018-11-13 |
|
4/A | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
A - Award | 875 | 6 299 | 16,13 | ||||
2018-11-07 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2018-11-07 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2018-11-07 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2018-11-07 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −2 216 | 0 | −100,00 | 49,27 | −109 182 | ||
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −3 784 | 2 216 | −63,07 | 47,56 | −179 967 | 105 393 | |
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 6 000 | 33,33 | 36,45 | 54 675 | 218 700 | |
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 4 500 | 50,00 | 34,64 | 51 960 | 155 880 | |
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 3 000 | 100,00 | 27,21 | 40 815 | 81 630 | |
2018-11-07 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 21,74 | 32 610 | 32 610 | ||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −2 112 | 0 | −100,00 | ||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 112 | 0,76 | ||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 077 | 3 077 | |||||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −2 112 | 0 | −100,00 | 45,50 | −96 096 | ||
2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 112 | 2 112 | |||||
2018-09-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 | 1 957 | 0,12 | ||||
2018-09-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 6 | 4 701 | 0,13 | ||||
2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 096 | 0,58 | ||||
2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 2 811 | 0,61 | ||||
2018-08-02 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
A - Award | 712 | 7 011 | 11,30 | ||||
2018-06-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 | 1 954 | 0,13 | ||||
2018-06-13 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 6 | 4 695 | 0,12 | ||||
2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 084 | 0,58 | ||||
2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 794 | 0,58 | ||||
2018-05-09 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 1 952 | 1 952 | |||||
2018-03-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 142 | 0,12 | ||||
2018-03-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 548 | 0,12 | ||||
2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 072 | 0,53 | ||||
2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 778 | 0,54 | ||||
2017-12-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 139 | 0,13 | ||||
2017-12-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 544 | 0,13 | ||||
2017-12-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-12-05 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −32 | 0 | −100,00 | 50,07 | −1 602 | ||
2017-12-05 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 468 | 32 | −97,87 | 50,48 | −74 105 | 1 615 | |
2017-12-05 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 49,42 | 74 130 | 74 130 | ||
2017-11-30 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-11-30 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-11-30 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-11-30 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −1 383 | 0 | −100,00 | 50,30 | −69 565 | ||
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −4 617 | 1 383 | −76,95 | 49,86 | −230 204 | 68 956 | |
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 6 000 | 33,33 | 27,11 | 40 665 | 162 660 | |
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 4 500 | 50,00 | 38,38 | 57 570 | 172 710 | |
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 3 000 | 100,00 | 47,71 | 71 565 | 143 130 | |
2017-11-30 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 40,34 | 60 510 | 60 510 | ||
2017-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 061 | 0,63 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 587 | 0 | −100,00 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 587 | 0,63 | ||||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 587 | 0 | −100,00 | 51,04 | −81 000 | ||
2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 587 | 1 587 | |||||
2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 381 | 1 381 | |||||
2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 808 | 6 808 | |||||
2017-09-28 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −6 865 | 0 | −100,00 | ||||
2017-09-28 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −6 865 | 0 | −100,00 | 48,88 | −335 592 | ||
2017-09-28 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 865 | 6 865 | 47,23 | 324 237 | 324 237 | ||
2017-09-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 137 | 0,13 | ||||
2017-09-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 541 | 0,13 | ||||
2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 577 | 0,64 | ||||
2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 048 | 0,59 | ||||
2017-08-01 |
|
4 | CMD |
CANTEL MEDICAL CORP
Common Stock, par value $.10 per share |
S - Sale | −1 453 | 5 424 | −21,13 | 77,56 | −112 698 | 420 696 | |
2017-06-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 134 | 0,13 | ||||
2017-06-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 538 | 0,13 | ||||
2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 567 | 0,71 | ||||
2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 036 | 0,69 | ||||
2017-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 131 | 2 131 | |||||
2017-03-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 534 | 0,13 | ||||
2017-03-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2017-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −58 | 0 | −100,00 | 47,63 | −2 763 | ||
2017-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 442 | 58 | −96,13 | 47,57 | −68 596 | 2 759 | |
2017-03-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 45,75 | 68 625 | 68 625 | ||
2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 556 | 0,65 | ||||
2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 022 | 0,65 | ||||
2016-12-15 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 3 | 2 531 | 0,13 | ||||
2016-12-08 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −5 737 | 0 | −100,00 | ||||
2016-12-08 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −7 451 | 0 | −100,00 | ||||
2016-12-08 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −13 188 | 0 | −100,00 | 43,05 | −567 743 | ||
2016-12-08 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 737 | 13 188 | 77,00 | 36,71 | 210 605 | 484 131 | |
2016-12-08 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 7 451 | 7 451 | 36,76 | 273 899 | 273 899 | ||
2016-12-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2016-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −101 | 0 | −100,00 | 45,15 | −4 560 | ||
2016-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 399 | 101 | −93,27 | 44,87 | −62 773 | 4 532 | |
2016-12-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 41,85 | 62 775 | 62 775 | ||
2016-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 546 | 0,78 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 448 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 448 | 0,77 | ||||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 448 | 0 | −100,00 | 34,99 | −50 666 | ||
2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 448 | 1 448 | |||||
2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 2 009 | 2 009 | |||||
2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 11 777 | 11 777 | |||||
2016-10-05 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
S - Sale | −1 453 | 5 424 | −21,13 | 77,56 | −112 698 | 420 696 | |
2016-09-14 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 4 | 2 528 | 0,15 | ||||
2016-09-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2016-09-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −130 | 0 | −100,00 | 41,63 | −5 412 | ||
2016-09-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 370 | 130 | −91,33 | 41,93 | −57 444 | 5 451 | |
2016-09-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 38,31 | 57 465 | 57 465 | ||
2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
2016-08-02 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
A - Award | 747 | 6 877 | 12,19 | ||||
2016-06-16 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 4 | 2 524 | 0,16 | ||||
2016-06-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2016-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −203 | 0 | −100,00 | 40,33 | −8 187 | ||
2016-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
D - Sale to Issuer | −1 297 | 203 | −86,47 | 40,33 | −52 308 | 8 187 | |
2016-06-02 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 34,89 | 52 335 | 52 335 | ||
2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 426 | 0,78 | ||||
2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 523 | 0,79 | ||||
2016-05-11 |
|
4 | L |
LOEWS CORP
Restricted Stock Units |
A - Award | 2 520 | 2 520 | |||||
2016-03-03 |
|
4 | L |
LOEWS CORP
Stock Option |
M - Exercise | −1 500 | 0 | −100,00 | ||||
2016-03-03 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −1 500 | 0 | −100,00 | 36,79 | −55 185 | ||
2016-03-03 |
|
4 | L |
LOEWS CORP
Common Stock |
M - Exercise | 1 500 | 1 500 | 34,18 | 51 270 | 51 270 | ||
2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 415 | 1,00 | ||||
2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 1 511 | 1,00 | ||||
2016-01-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2015-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 401 | 0,79 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 496 | 1 496 | |||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 7 451 | 7 451 | |||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 259 | 0 | −100,00 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 259 | 0,80 | ||||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 259 | 0 | −100,00 | 36,11 | −45 462 | ||
2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 259 | 1 259 | |||||
2015-10-05 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
S - Sale | −2 462 | 6 130 | −28,65 | 56,67 | −139 526 | 347 399 | |
2015-10-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 390 | 0,72 | ||||
2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 249 | 0,73 | ||||
2015-08-04 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
A - Award | 927 | 8 592 | 12,09 | ||||
2015-07-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 380 | 0,66 | ||||
2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 240 | 0,65 | ||||
2015-04-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2015-03-16 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
S - Sale | −3 135 | 7 665 | −29,03 | 45,96 | −144 085 | 352 283 | |
2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 371 | 0,66 | ||||
2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 232 | 0,65 | ||||
2015-01-05 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2014-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 224 | 0,74 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 362 | 1 362 | |||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 737 | 5 737 | |||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 870 | 0 | −100,00 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 870 | 0,75 | ||||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −1 870 | 0 | −100,00 | 36,83 | −68 872 | ||
2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 870 | 1 870 | |||||
2014-10-14 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
S - Sale | −3 750 | 10 800 | −25,77 | 37,00 | −138 750 | 399 600 | |
2014-10-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 215 | 0,58 | ||||
2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 856 | 0,60 | ||||
2014-08-01 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
A - Award | 1 453 | 14 550 | 11,09 | ||||
2014-07-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 208 | 0,67 | ||||
2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 845 | 0,60 | ||||
2014-04-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 200 | 0,59 | ||||
2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 834 | 0,55 | ||||
2014-01-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2013-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 824 | 0,61 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 193 | 1 193 | |||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −2 167 | 0 | −100,00 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 167 | 0,56 | ||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 045 | 4 045 | |||||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | −2 167 | 0 | −100,00 | 41,90 | −90 797 | ||
2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 167 | 2 167 | |||||
2013-10-08 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
S - Sale | −4 875 | 13 097 | −27,13 | 32,21 | −157 009 | 421 814 | |
2013-10-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2013-09-23 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −5 680 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −5 680 | 0 | −100,00 | 40,83 | −231 906 | ||
2013-09-23 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 680 | 5 680 | 28,23 | 160 329 | 160 329 | ||
2013-08-16 |
|
4 | L |
LOEWS CORP
Common Stock |
S - Sale | −10 400 | 0 | −100,00 | 47,58 | −494 832 | ||
2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 813 | 0,50 | ||||
2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 155 | 0,51 | ||||
2013-08-02 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
A - Award | 1 337 | 17 972 | 8,04 | ||||
2013-07-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 804 | 0,50 | ||||
2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 144 | 0,52 | ||||
2013-04-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2013-03-28 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −4 902 | 0 | −100,00 | ||||
2013-03-28 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −4 902 | 0 | −100,00 | 40,81 | −200 074 | ||
2013-03-28 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 902 | 4 902 | 28,69 | 140 618 | 140 618 | ||
2013-03-21 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −8 197 | 0 | −100,00 | ||||
2013-03-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −8 197 | 0 | −100,00 | 40,51 | −332 034 | ||
2013-03-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 8 197 | 8 197 | 29,39 | 240 898 | 240 898 | ||
2013-02-26 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −8 709 | 0 | −100,00 | ||||
2013-02-26 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −8 709 | 0 | −100,00 | 38,76 | −337 570 | ||
2013-02-26 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 8 709 | 8 709 | 27,69 | 241 154 | 241 154 | ||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −4 883 | 0 | −100,00 | ||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −4 883 | 0 | −100,00 | 36,33 | −177 393 | ||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 883 | 4 883 | 27,50 | 134 258 | 134 258 | ||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 883 | 4 883 | |||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 680 | 5 680 | |||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 902 | 4 902 | |||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 865 | 6 865 | |||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 8 197 | 8 197 | |||||
2013-02-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 8 709 | 8 709 | |||||
2013-01-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 795 | 0,62 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 55 | 1 784 | 3,18 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 133 | 0,61 | ||||
2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 65 | 2 120 | 3,16 | ||||
2012-11-27 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −6 266 | 0 | −100,00 | 25,06 | −157 026 | ||
2012-11-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −6 266 | 0 | −100,00 | 31,88 | −199 747 | ||
2012-11-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 266 | 6 266 | 25,06 | 157 026 | 157 026 | ||
2012-11-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 055 | 0,69 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 729 | 1 729 | |||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | −1 799 | 0 | −100,00 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 799 | 0,73 | ||||
2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 543 | 5 543 | 28,92 | 160 304 | 160 304 | ||
2012-10-12 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | −5 800 | 0 | −100,00 | ||||
2012-10-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | −5 800 | 0 | −100,00 | 29,00 | −168 200 | ||
2012-10-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 800 | 5 800 | 21,99 | 127 542 | 127 542 | ||
2012-10-01 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 041 | 0,74 | ||||
2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 786 | 0,73 | ||||
2012-08-02 |
|
4 | CMN |
CANTEL MEDICAL CORP
Common Stock |
A - Award | 1 340 | 11 090 | 13,74 | ||||
2012-07-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 026 | 0,75 | ||||
2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 773 | 0,74 | ||||
2012-04-02 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 2 250 | 2 250 | |||||
2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 011 | 0,80 | ||||
2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 760 | 0,80 | ||||
2012-01-03 |
|
4 | L |
LOEWS CORP
Stock Appreciation Right |
A - Award | 1 500 | 1 500 | |||||
2006-06-30 |
|
4 | LTR;CG |
LOEWS CORP
Stock Appreciation Right |
A - Award | 1 500 | 1 500 | |||||
2006-01-20 | 3 | LTR:CG |
LOEWS CORP
Common Stock |
500 |